Call your doctor before leaving home if you think you’ve been exposed to COVID-19 or have symptoms

Due to the presence of COVID-19 in our community, visitor restrictions are in place for all Duke clinics and hospitals. For your safety and the safety of others, we recommend patients do not bring a visitor to Duke clinics, if at all possible. If a visitor must accompany a patient, only one individual over 12 years of age is allowed. Patients and visitors will be screened for symptoms upon arrival. Individuals with flu-like symptoms are not allowed. View the complete list of Visitor Restrictions.

Effective immediately, Duke Health is prioritizing and rescheduling some non-emergent or non-critical surgeries, procedures, and appointments. Check our COVID-19 (Coronavirus) page for updates.

Rare Breast Tumor Registry - Clinical Trial

What is the Purpose of this Study?

We created this registry for people with rare breast tumors to help us learn more about them and how to better treat people in the future.
What is the Condition Being Studied?
Rare Breast Tumors

Who Can Participate in the Study?

Adults diagnosed with a rare breast tumor such as a fibroepithelial lesion, phyllodes tumor, or primary breast sarcoma.

Age Group

What is Involved?

If you choose to join this study, you will:
- Allow us to collect your medical history from your electronic health record
- Give a blood sample
- Give a tissue sample

Study Details

Full Title
Contemporary Management and Comparison of Rare Breast Tumors (Fibroadenomas, Phyllodes Tumors, and Primary Breast Sarcomas); A Prospective Registry
Principal Investigator
Surgical Oncologist
Protocol Number
IRB: PRO00102502
Phase N/A
Contact the Duke Recruitment Innovation Center